Eduardo J. Gallastegui Armella

Advised a research healthcare company in two successful amparo trials for products intended for oncology purposes, the acquisition of two pharmaceutical manufacturers, the contesting of several awards to public auctions related to the acquisition of drugs by public sector agencies, and all antitrust, intellectual property and litigation related matters.

Advised a research healthcare company on the crisis management related to the alleged insufficiency of a product during the flu epidemic in 2009 and the 2015-2016 flu season

Counseled a pharmaceutical company on the development, manufacturing and commercialization of the first Mexican vaccine against the flu. The services included the implementation of an in-bond scenario to allow the performance of certain secondary processes in France

Counseled a pharmaceutical company in connection with antitrust, intellectual property and compliance matters, as well as with various regulatory procedures, specifically related to the obtainment and modification of the conditions of the sanitary registration of drugs (ie, marketing authorizations) from the competent health authorities and Mexican FDA

Assisted in the preparation, negotiation and lobbying of the amendments related to the General Health Law in order to establish legislation to biosimilar drugs in Mexico

• Board, US-Mexico Chamber of Commerce
• Independent Director and Member of the Audit Committee, GMexico Transportes
• Director, Grupo Ferroviario Mexicano, S.A. de C.V. and Ferrocarril Mexicano
• Director, Fundación Dondé Banco, S.A.
• Chairman of the Board, Club de Golf Malinalco, S.A. de C.V.
• Chairman of the Board, Real Malinalco, S.A. de C.V., Chairman of the Board
• Chairman, San Sebastián Ecológico, S.A. de C.V.
• Chairman of the Board, Fairmont Heritage Place Acapulco